Irvine’s Hycor Biomedical Buys Medical Specialties
- Share via
IRVINE — Hycor Biomedical Inc. said Tuesday it has completed its purchase of Medical Specialties International Inc.
Hycor, an Irvine-based developer of medical diagnostic equipment, said it paid $2 million cash and 200,000 shares of its own stock for Medical Specialties, a South Plainfield, N.J., company that develops blood testing technology.
Based on Tuesday’s Nasdaq closing price of $4.625 a share for Hycor’s stock, the total value of the transaction is about $2.9 million.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.